Searchable abstracts of presentations at key conferences in endocrinology

ea0062p40 | Poster Presentations | EU2019

Hypopituitarism and hyperprolactinemia secondary to a sella/suprasellar mass consistent with metastatic lung adenocarcinoma

Mitchell Antonine Pineau , Khanam Amina , Charles Debbie-Ann , Tremble Jennifer

Case history: A 68 year old woman was referred to Endocrinology with a history of vomiting, extreme fatigue of acute onset and non-specific visual changes. She had a history of primary hypothyroidism and an adenocarcinoma of the lung with bone metastases initially been treated with pemetrexed and cisplatin chemotherapy. The patient subsequently required palliative radiotherapy for metastatic spinal cord compression and was started on denosumab. Imaging shortly before her refer...

ea0062p39 | Poster Presentations | EU2019

Hypophysitis secondary to pembrolizumab use in primary lung carcinoma with brain and adrenal metastasis: An evaluation of hormone replacement and future management

Khanam Amina , Mitchell Antonine Pineau , Khan Madeha , Charles Debbie-Ann , Tremble Jennifer

Case history: A 72 year old male was diagnosed with primary lung adenocarcinoma grade T4N2M1b with adrenal and brain metastasis 1 year previously. On diagnosis his tumour was strongly positive for PDL-1 expression. This patient was started on dexamethasone 8 mg once a day that was weaned down to 4mg twice daily and then slowly weaned off steroids whilst receiving whole brain radiation. He was started on pembrolizumab therapy and had received ten cycles of treatment when he beg...